Drugs are now available that can slow the progression of cancer cells.

Canadian researchers are developing a new drug that could slow the progression of cancer cells.

This information was announced by Dr. Tak Mak, Director of the Margaret Cancer Research Centre in Toronto, Canada, at a press conference on June 18th in the city.

Dr. Tak Mak, Director of the Margaret Cancer Research Center.
(Source: ctvnews.ca)

Dr. Mak stated that his research team is developing the drug CFI-400.945, which inhibits PLK4, an enzyme crucial for cell division, particularly in cancer cells.

Experimental results on mice also showed that the drug CFI-400.945 has the ability to inhibit the growth of breast and ovarian cancer. This drug is also effective against colorectal cancer, glioblastoma (the most aggressive type of brain cancer), lung cancer, skin cancer, pancreatic cancer, and prostate cancer.

Currently, the research team is awaiting approval from Health Canada so that they can begin clinical trials on humans in the coming months.

Dr. Mak said that the research team cannot yet promise the effectiveness of the new drug in treating cancer, but he believes it is an important discovery that has the potential to increase the effectiveness of treatment for cancer patients.

In addition to CFI-400.945, the research team is also developing other drugs targeting newly discovered proteins.

According to (VNA) - VT